Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2015-02-23 08:41 |
Fagron NV: Disclosure of acquisition of treasury shares
|
English | 208.8 KB | ||
| 2015-02-23 00:00 |
Carmignac Gestion - Fagron - Positions - 2015.pdf
|
Dutch | 226.6 KB | ||
| 2015-02-23 00:00 |
20150223 ENG Final Press release notification.pdf
|
English | 215.6 KB | ||
| 2015-02-23 00:00 |
20150223 NL Final Persbericht kennisgeving.pdf
|
Dutch | 240.9 KB | ||
| 2015-02-23 00:00 |
ENG Press Release treasury shares Final.pdf
|
English | 208.8 KB | ||
| 2015-02-23 00:00 |
NL Persbericht inkoop eigen aandelen Final.pdf
|
Dutch | 237.2 KB | ||
| 2015-02-06 08:28 |
CORRECTION: Fagron NV: Omzet stijgt met 30,4% naar € 447,1 miljoen
|
Dutch | 2.9 MB | ||
| 2015-02-06 08:24 |
Fagron NV: Turnover growth of 30.4% to € 447.1 million
|
English | 1.5 MB | ||
| 2015-02-06 08:24 |
Fagron NV: Turnover growth of 30.4% to € 447.1 million
|
English | 1.7 MB | ||
| 2015-02-06 00:00 |
Turnovergrowth of 30.4%
|
English | 2.5 MB | ||
| 2015-02-06 00:00 |
Omzetgroei van 30,4%
|
Dutch | 2.9 MB | ||
| 2015-01-12 08:33 |
Fagron NV: Disclosure of acquisition of treasury shares
|
English | 230.5 KB | ||
| 2015-01-12 08:33 |
Fagron NV: Disclosure of acquisition of treasury shares
|
English | 199.5 KB | ||
| 2015-01-12 00:00 |
PR Fagron ENG share buyback_V12jan.pdf
|
English | 199.5 KB | ||
| 2015-01-12 00:00 |
PR Fagron NL inkoop eig aand_V12janMP.pdf
|
Dutch | 230.5 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
